latest news releases from the newsroom
Momo Special Committee Retains Financial Advisor and Legal Counsel
BEIJING, July 29, 2015 (GLOBE NEWSWIRE) -- Momo Inc. (Nasdaq:MOMO) ("Momo" or the "Company"), a leading mobile social networking platform in China, today announced that the special committee (the "Special Committee") of the Company's board of directors has retained J.P. Morgan Securities (Asia Pacific) Limited as its financial advisor, Shearman & Sterling LLP as its United States legal counsel and Conyers Dill & Pearman as its Cayman Islands legal counsel in connection with its review and evaluation of the previously announced preliminary non-binding "going private" proposal letter that the Company's board of directors received on June 23, 2015.
WestRock Reports Strong Fiscal 2015 Third Quarter
NORCROSS, Ga., July 29, 2015 (GLOBE NEWSWIRE) -- WestRock Company (WestRock) (NYSE:WRK) today announced results for its fiscal third quarter, which ended June 30, 2015. On July 1, 2015, Rock-Tenn Company (RockTenn) and MeadWestvaco Corporation (MeadWestvaco) completed a strategic combination of their respective businesses. After completion of this transaction, RockTenn and MeadWestvaco became wholly owned subsidiaries of WestRock. In this release, the Company has presented selected financial results for the quarter ended June 30, 2015, for RockTenn and MeadWestvaco and has shown combined results for certain metrics.
Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock
SHELTON, Conn., July 29, 2015 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced the pricing of its underwritten public offering of 3,763,440 shares of its common stock at a public offering price of $18.60 per share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Cara Therapeutics, are expected to be approximately $70 million. In addition, Cara Therapeutics granted the underwriters a 30-day option to purchase up to 564,516 additional shares of common stock at the public offering price, less the underwriting discounts and commissions. All of the shares in the offering will be sold by Cara Therapeutics.
Lundin Mining Corporation
LUNDIN MINING SECOND QUARTER RESULTS
Toronto, July 29, 2015 (TSX: LUN; OMX: LUMI) Lundin Mining Corporation (“Lundin
Mining” or the “Company”) today reported net earnings of $53.7 million or net
earnings attributable to Lundin shareholders (after deducting non-controlling
interests) of $46.4 million ($0.06 per share) for the quarter ended June 30,
2015. Cash flows of $262.7 million were generated from operations in the
quarter, not including the Company’s attributable cash flows from Tenke
Earnings for the three month